Synflorix™, GlaxoSmithKline’s pneumococcal vaccine, receives European authorisation

Sanofi to Stop Disparaging Rival Flu Vaccine to Stave Off EU Antitrust Fine

FDA advisory panel recommends updating fall Covid vaccines to target XFG variant

An FDA advisory panel recommended updating fall 2025 Covid-19 vaccines to target the XFG variant ("stratus"), a fast-growing strain. The rec

Modelling impacts of paediatric amoxicillin shortage management on pneumococcal resistance and invasive disease in Europe

A Study to Investigate the Difference In Blood Levels of Camlipixant Between Different Camlipixant Formulation Prototypes

Commission seeks feedback on commitments offered by Sanofi over possible anticompetitive conduct regarding the promotion of a flu vaccine for vulnerable patients

Commission opens investigation into possible anticompetitive conduct by Sanofi regarding the promotion of a flu vaccine for vulnerable patients